CIK: 0001953107
Total reported value
$351.5M
Reporting period: 2026-03-31 · Number of holdings: 7
ENAVATE SCIENCES GP, LLC disclosed 7 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $351.5M and a quarterly turnover rate of 36.2%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "E"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Terms of Use for AI
AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/13f/enavate-sciences-gp-llc
Add SION
0.0% -$2.6M
Trim UPB
0.0% -$44.6M
Trim ZBIO
0.0% -$65.7M
Add CMPX
0.0% -$623.1K
Add IMNM
-24.2% -$23.4M
Trim CAMP
-27.8% -$8.9M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | SION | Sionna Therapeutics INC | Stock-Other | 28.26% | +8.14% | — | |
| 2 | IMNM | Immunome INC | Stock-Other | 22.48% | +2.27% | -24.22% | |
| 3 | ZBIO | Zenas Biopharma INC | Stock-Other | 21.80% | -6.28% | — | |
| 4 | CMPX | Compass Therapeutics INC | Stock-Other | 11.72% | +3.47% | — | |
| 5 | BBOT | Bridgebio Oncology Therapeut | Stock-Other | 6.69% | +0.20% | — | |
| 6 | UPB | Upstream Bio INC | Stock-Other | 6.30% | -6.88% | — | |
| 7 | CAMP | Camp4 Therapeutics CORP | Stock-Other | 2.75% | -0.92% | -27.83% |
Performance for Q3 2026
+31.4%
Performance Last 4 Quarters
+101.3%
Based on 71% of reported portfolio value with available pricing
Not enough sector-mapped data yet
Enavate Sciences Gp, LLC's most significant position changes for 2026-03-31: Trim: Immunome INC (IMNM) — shares -24.22%; Trim: Camp4 Therapeutics CORP (CAMP) — shares -27.83%.
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | SION | Sionna Therapeutics INC | +8.1% | — | Unchanged |
| 2 | CMPX | Compass Therapeutics INC | +3.5% | — | Unchanged |
| 3 | IMNM | Immunome INC | +2.3% | -24.22% | Trim |
| 4 | BBOT | Bridgebio Oncology Therapeut | +0.2% | — | Unchanged |
| 5 | CAMP | Camp4 Therapeutics CORP | -0.9% | -27.83% | Trim |
| 6 | ZBIO | Zenas Biopharma INC | -6.3% | — | Unchanged |
| 7 | UPB | Upstream Bio INC | -6.9% | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001963875
Total reported value
$351.5M
85 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0002069023
Total reported value
$351.6M
649 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001671811
Total reported value
$351.7M
41 stks
2018-12-31
Stale — no recent filing
AUM within 0.1% of this institution
Institutions with overlapping top holdings
CIK 0001346824
Total reported value
$9.4B
86 stks
2026-03-31
1 of the top 5 holdings overlap, including Sionna Therapeutics INC
CIK 0001425738
Total reported value
$1.5B
35 stks
2026-03-31
1 of the top 5 holdings overlap, including Immunome INC
CIK 0001545692
Total reported value
$176.2M
5 stks
2026-03-31
1 of the top 5 holdings overlap, including Zenas Biopharma INC